← Open Payments lookup

JENNIFER BURKE-BRYANT: Open Payments

NPI 1407431729 · LOUISA, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$813 in 60 payments from 12 companies in 2025. Trend: 2023 $161 · 2024 $256 · 2025 $813

Food & beverage: $813
CompanyPaymentsAmount
ABBVIE INC.22$212
Neurocrine BioSciences, Inc.12$142
Corium, LLC7$97
Axsome Therapeutics, Inc.3$83
Otsuka America Pharmaceutical, Inc.3$60
Alkermes, Inc.3$48
Sage Therapeutics, LLC2$37
E.R. Squibb & Sons, L.L.C.2$36
Teva Pharmaceuticals USA, Inc.2$32
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$28

Products named: VRAYLAR, INGREZZA, Azstarys, Auvelity, REXULTI, LYBALVI, ZURZUVAE, COBENFY.

Industry payments across KY — which companies pay providers there.